Workflow
Revenue Target
icon
Search documents
United States Antimony targets $125M 2026 revenue with expanded contracts and mining projects (NYSE:UAMY)
Seeking Alpha· 2026-03-19 22:22
Earnings Call InsightsUnited States Antimony targets $125M 2026 revenue with expanded contracts and mining projectsMar 19, 2026, 6:22 PM ETUnited States Antimony Corporation (UAMY) StockAI-Generated Earnings Calls InsightsComment(1)Earnings Call Insights: United States Antimony Corporation (UAMY) Q4 2025 Management View CEO Gary Evans highlighted several major developments, including the acquisition of a tungsten property in Ontario, Canada, now holding an inferred resource value exceeding $4.6 billion. Eva ...
Turtle Beach targets $335M–$355M revenue for 2026 as product launches and GTA 6 drive outlook (NASDAQ:TBCH)
Seeking Alpha· 2026-03-12 23:32
Management View - Turtle Beach Corporation's CEO Cristopher Keirn highlighted that 2025 was a challenging year for the broader industry, testing the company's resilience and execution discipline due to global tariff impacts and market softness [2]. Revenue Outlook - The company is targeting a revenue range of $335 million to $355 million for 2026, driven by upcoming product launches and the anticipated release of Grand Theft Auto 6 [2].
Concrete Pumping outlines $390M–$410M revenue target for 2026 while data center demand accelerates (NASDAQ:BBCP)
Seeking Alpha· 2026-03-10 22:40
Core Insights - Concrete Pumping Holdings, Inc. (BBCP) aims for a revenue target of $390 million to $410 million by 2026, reflecting a positive outlook amid increasing demand in the data center sector [2] Group 1: Financial Performance - In Q1 2026, Concrete Pumping Holdings reported a 5% year-over-year increase in revenue, indicating a strong start to the year [2] - Adjusted EBITDA for the same period rose by 6%, driven by a return to operational stability [2]
Aquestive plans 75-rep Anaphylm launch and targets $46M–$50M in 2026 revenue while doubling medical affairs (NASDAQ:AQST)
Seeking Alpha· 2026-03-05 18:16
Management View - Aquestive Therapeutics is optimistic about its future, with CEO Daniel Barber stating that the company's path has never been clearer [2] - The company plans to launch a 75-rep Anaphylm and targets revenue between $46 million and $50 million in 2026 [2] - There is a commitment to doubling the medical affairs team to support growth initiatives [2]
Temple & Webster (ASX:TPW) share price plunges 28% on FY26 trading update
Rask Media· 2025-11-26 00:45
Core Viewpoint - Temple & Webster Group Ltd experienced a significant share price drop of 28% following its trading update for FY26, despite reporting positive revenue growth and market share gains [1][7]. Group 1: Trading Performance - Revenue from July 1 to November 20, 2025, increased by 18% year on year, indicating strong market share growth [2]. - The home improvement segment showed exceptional performance with over 40% year-on-year revenue growth, while the trade & commercial segment grew by 23% year on year [3]. - Average order values rose by 3% year on year, and active customers reached record levels, with a growing proportion of repeat customers [2][3]. Group 2: Financial Goals and Position - The company remains on track to achieve its mid-term goal of $1 billion in annual revenue by FY28, with an EBITDA margin target of 3-5% for FY26 [4]. - Temple & Webster has a strong cash position exceeding $150 million, enabling it to pursue an on-market share buy-back [4]. Group 3: Expansion Efforts - The company launched shipping to New Zealand in October 2025, generating over $100,000 in revenue within the first six weeks and attracting multiple repeat customers [5][6]. - The investment in New Zealand is projected to incur additional costs of $2 million to $3 million for FY26, but the market opportunity is considered attractive due to the lack of mid-market online players in the region [5][6]. Group 4: Market Sentiment - The recent trading update indicates a deceleration in revenue growth compared to the previous period, raising concerns about future sales performance [7]. - Despite the share price decline, there is a belief that this could present a buying opportunity for investors who maintain confidence in the company's long-term prospects [8][9].